ENThere is no approved, routine stem cell treatment for liver cirrhosis in Germany. Patients and their families usually start looking for stem cells after two sentences: “cirrhosis” and “there is nothing more to be done”. The search is understandable: scarred liver tissue does not go back to what it was, and online promises are far louder than reality.
Below: where stem cells stand in cirrhosis today, what the trials say, where such treatment is legally permitted and how German hospitals actually treat cirrhosis. We promise neither a cure nor a reversal of cirrhosis. For the wider picture, see liver cirrhosis treatment in Germany.
What cirrhosis is, and why the stem cell question comes up
Cirrhosis is the end stage of long-standing liver disease: years of inflammation replace working liver tissue with dense connective tissue. This scarring is called fibrosis; in cirrhosis it has rebuilt the architecture of the organ, and blood struggles to pass through it.
The commonest causes are hepatitis B and C, alcohol, metabolic fatty liver disease, and autoimmune and bile duct diseases; inherited causes are rarer. The cause is not a historical footnote: the whole treatment is built on it.
Stem cells come up because the liver can regenerate, hence the idea that cells might drive that regeneration or hold fibrosis back. The idea has been studied for years and has not become standard treatment.
What the trials and the law say today
In short, reliable evidence is lacking and the legal limits are strict. Trial results are inconsistent, the groups are small and follow-up is short, and the German cirrhosis guidelines of the gastroenterology society DGVS contain no recommendation for stem cells outside research; the current version dates from 2018 and is being updated. The absence of a recommendation does not forbid research; it forbids presenting this as proven treatment.
In Germany, cell preparations are medicinal products subject to authorisation, overseen by the Paul-Ehrlich-Institut, and they are used in university hospitals inside approved studies with ethics committee approval. Anyone promising “a stem cell injection for the liver” for a fixed fee is working outside that frame. See is stem cell therapy legal in Germany and stem cell therapy: what is proven and what is not.
In practice, if you are offered cells, ask for the name and number of the study, the ethics approval, the inclusion criteria and who pays. Without written answers, this is not medical treatment. Reliable information on viral hepatitis, a common cause of cirrhosis, comes from the WHO, for example its fact sheet on hepatitis B.
How cirrhosis is actually treated in Germany
In reality, cirrhosis is treated above all through its cause: antiviral drugs in hepatitis B and C, complete abstinence from alcohol, a metabolic plan in fatty liver disease, and immunosuppressive or bile-acid drugs in autoimmune disease. Stopping the cause is what stops the progression, and part of the liver’s function may improve afterwards.
The second task is the complications: oesophageal varices and prevention of bleeding, fluid in the abdomen, hepatic encephalopathy (brain disturbance from toxins the liver no longer clears), infections, and malnutrition with loss of muscle mass. This work genuinely changes a patient’s life, and hepatology departments do it as routine care, not as an experiment.
A liver transplant is discussed when the liver stops coping despite treatment. The assessment is formalised: the patient is examined in a transplant centre, whose interdisciplinary transplant conference decides on listing. German allocation rules are strict: under the Transplantation Act, Eurotransplant allocates deceased donor organs mainly by urgency and chance of success. A foreign patient’s position differs from a resident’s: a transplant centre decides whether to list a patient from abroad, and Eurotransplant has no part in that decision. See liver transplant in Germany.
Who decides and who follows the patient
A hepatologist-gastroenterologist decides and follows the patient together with a radiologist, an anaesthetist and a dietitian, plus a tumour board where cancer is involved. The stem cell question belongs to this team, not to a private clinic selling injections. Such specialists include Prof. Martina Müller-Schilling, director of the Department of Internal Medicine I at University Hospital Regensburg, whose field is gastroenterology and oncology, and Prof. Christian Rust, head of department and one of the directors of the Liver Cancer Centre at Barmherzige Brüder Hospital in Munich.
A second opinion often shows that the degree of fibrosis was misjudged, that the cause was never properly treated, or that the patient should be referred for transplant assessment. To understand what that market offers, see stem cell clinics in Germany.
Frequently asked questions
Can cirrhosis be cured with stem cells?
No. There is no approved stem cell treatment for cirrhosis: trial results are inconsistent, the groups are small and follow-up is short, so cell therapy has not shown that it can cure or reverse cirrhosis. Real benefit comes from treating the cause and the complications and, if the liver stops coping, from transplant assessment.
How do I join a cell therapy study for cirrhosis?
Only through a centre running an approved study, and only if you meet its criteria. Ask your hepatologist whether a suitable study exists and request its name and number, the ethics approval and the inclusion criteria, plus a written answer on who pays. The centre decides on participation by protocol, not a seller of “therapy”.
Is it worth travelling to Germany for stem cells for cirrhosis?
Travel for an assessment, not for cells. A hepatology department checks the degree of fibrosis and the cause, plans treatment of the cause and the complications and, if needed, refers the patient to a transplant centre for assessment. If a suitable cell therapy study exists, the centre running it decides on participation by its own criteria.
How AlenMed arranges the treatment
AlenMed sends the discharge summary, laboratory results and images to a hepatology department at one of 86 partner hospitals in 38 German cities; the company works with 345 doctors, and its office is in Munich. It does not arrange “stem cell injections for the liver” on request: it arranges a medical assessment and a written plan, with a translated discharge summary, the hospital’s written reply, the invitation letter, the medical visa and an interpreter.
Ask in advance: the exact diagnosis and degree of fibrosis, the plan for the cause and the complications, whether transplant assessment is on the table, who follows the patient after the return home, and which documents they take with them.
This material is for information only and is not an offer. The treatment plan is decided by a doctor at an in-person consultation.
News on this topic
Preventing Stomach Cancer Before It Starts: Breakthrough at Charité
Researchers at Charité have discovered how Helicobacter pylori reprograms stomach tissue, creating new possibilities for early molecular cancer prevention.
Approved Drug Shows Potential in Preventing Severe Pancreatitis
Researchers at Universitätsmedizin Greifswald showed that Anakinra can reduce tissue damage and scarring in acute and chronic pancreatitis.
